Over the past year, shares of Globus Medical GMED and Medtronic MDT have gained 46.1% and 7.6%, respectively, significantly ...

Medtronic (NYSE:MDT) is one of the best long term stocks to buy according to hedge funds. On June 8, Medtronic received FDA ...

Abstract: Human neuroscience is undergoing a paradigm shift from traditional lab settings to natural environments. Functional Near Infrared Spectroscopy (fNIRS) and its variant, High-Density Diffuse ...

On June 25, Allan Small, Senior Investment Advisor at Allan Small Financial Group, appeared on BNN Bloomberg to discuss ...

Abstract: Oxygen saturation (SpO2) is a vital parameter in clinical practice. Clinical research suggests that SpO2 may significantly decrease in patients with lung infections before evident symptoms, ...

The goal of Sony’s PlayStation Pulse Explore wireless earbuds can be distilled down to two features: high-quality detailed audio and a plug-and-play setup. Clearly, Sony wanted these earbuds to stand ...

When implemented in routine health systems at primary care level in Kenya and Senegal, pulse oximetry and CDSAs were not found to be associated with an increase in urgent referrals but likely mediated ...

EDITOR’S NOTE: This story contains descriptions of gun violence that some readers may find disturbing. Bass pumped through Pulse nightclub in the early hours of June 12, 2016, as more than 300 people ...

Medtronic (NYSE:MDT) agreed to acquire SPR Therapeutics to expand its chronic pain care offerings with minimally invasive neuromodulation treatments. The company also secured FDA clearance for its ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.

June 8, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor. The Nell-EQ™ ...

The new Nasdaq IPO Pulse Index functions as a leading indicator for the IPO Market by forecasting the direction of US IPO activity over the next six months. IPO activity rises and falls in cycles. You ...